Dimension Inx

Hyperelastic Bone® represents a new generation of regenerative biomaterials that leverages our unique approach to restoring functionality in the body through a dynamic collaboration between biology and 3d-printed biomaterials. Our first product made from this novel technology is CMFlex™, a ready-to-use bone graft substitute that is the first 3D-printed regenerative bone product cleared by the U.S. Food and Drug Administration (FDA) for facial reconstruction applications. CMFlex offers a safe and effective alternative to traditional bone grafts – one that can save valuable time during surgical procedures and transform the current standard of care.